169 related articles for article (PubMed ID: 33120849)
21. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.
Corbacioglu S; Richardson PG
Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):885-898. PubMed ID: 28825848
[TBL] [Abstract][Full Text] [Related]
22. Retrospective Application of Sinusoidal Obstruction Syndrome/Veno-occlusive Disease Diagnostic Criteria in a Pediatric Hematopoietic Stem Cell Transplant Cohort.
Dhir A; Wadhwa A; Haines H; Chewning J; Murthy S; Kim J; Beatty L; Mixon E; Fowler KB; Gage J; Meadows T; Goldman F
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e343-e348. PubMed ID: 35200220
[TBL] [Abstract][Full Text] [Related]
23. The use of defibrotide in blood and marrow transplantation.
Richardson PG; Carreras E; Iacobelli M; Nejadnik B
Blood Adv; 2018 Jun; 2(12):1495-1509. PubMed ID: 29945939
[TBL] [Abstract][Full Text] [Related]
24. Incidence and risk factors of hepatic veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation in adults with prophylactic ursodiol and intravenous heparin or prostaglandin E1.
Yoon JH; Min GJ; Park SS; Park S; Lee SE; Cho BS; Eom KS; Kim YJ; Min CK; Cho SG; Kim DW; Lee JW; Kim HJ; Lee S
Bone Marrow Transplant; 2021 Jul; 56(7):1603-1613. PubMed ID: 33526915
[TBL] [Abstract][Full Text] [Related]
25. Gallbladder wall oedema and ascites are independent predictors of progression to hepatic veno-occlusive disease for children with hematopoietic stem cell transplantation.
Park JE; Choi YH; Cheon JE; Kim WS; Kim IO; Ryu YJ; Kim YJ; Hong CR; Kang HJ
Eur Radiol; 2018 Jun; 28(6):2291-2298. PubMed ID: 29294155
[TBL] [Abstract][Full Text] [Related]
26. Reliability of an ultrasonographical scoring system for diagnosis of sinusoidal obstruction syndrome/veno-occlusive disease in patients with hematopoietic stem cell transplantation.
Iwai T; Nishida M; Sugita J; Kudo Y; Takasugi R; Yokota I; Takagi R; Shibuya H; Takahashi S; Teshima T
J Med Ultrason (2001); 2021 Jan; 48(1):45-52. PubMed ID: 33398544
[TBL] [Abstract][Full Text] [Related]
27. A Retrospective Analysis of Antithrombin III Replacement Therapy for the Treatment of Hepatic Sinusoidal Obstruction Syndrome in Children Following Hematopoietic Stem Cell Transplantation.
Kim M; Rao S; Eickhoff JC; DeSantes KB; Capitini CM
J Pediatr Hematol Oncol; 2020 Mar; 42(2):145-148. PubMed ID: 30676436
[TBL] [Abstract][Full Text] [Related]
28. Nutrition challenges in a patient with sinusoidal obstructive syndrome following an allogeneic stem cell transplant: a case study.
Ringo K; Chen L
Nutr Clin Pract; 2012 Oct; 27(5):651-4. PubMed ID: 22892273
[TBL] [Abstract][Full Text] [Related]
29. Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT.
Battipaglia G; Labopin M; Candoni A; Fanin R; El Cheikh J; Blaise D; Michallet M; Ruggeri A; Contentin N; Ribera JM; Stadler M; Sierra J; von dem Borne PA; Bloor A; Socié G; Nagler A; Mohty M
Bone Marrow Transplant; 2017 Apr; 52(4):592-599. PubMed ID: 28092357
[TBL] [Abstract][Full Text] [Related]
30. Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party.
Bazarbachi AH; Al Hamed R; Labopin M; Halaburda K; Labussiere H; Bernasconi P; Schroyens W; Gandemer V; Schaap NPM; Loschi M; Jindra P; Snowden J; Wu D; Guffroy B; Rovira M; Chantepie SP; Poiré X; Lopez-Corral L; Nikolousis M; Pelosini M; Ciceri F; Baron F; Bazarbachi A; Corbacioglu S; Savani BN; Peric Z; Nagler A; Carreras E; Mohty M
Bone Marrow Transplant; 2021 Apr; 56(4):917-927. PubMed ID: 33208915
[TBL] [Abstract][Full Text] [Related]
31. Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.
Roeker LE; Kim HT; Glotzbecker B; Nageshwar P; Nikiforow S; Koreth J; Armand P; Cutler C; Alyea EP; Antin JH; Richardson PG; Soiffer RJ; Ho VT
Biol Blood Marrow Transplant; 2019 Jan; 25(1):137-144. PubMed ID: 30081073
[TBL] [Abstract][Full Text] [Related]
32. [Usefulness of serum plasminogen activator inhibitor-1 for diagnosis and monitoring of late-onset sinusoidal obstruction syndrome after allogeneic stem cell transplantation].
Ito S; Taguchi J; Kato J; Nakaya A; Tachibana T; Takemura S; Sano A; Ohata M; Ishigatsubo Y; Fujita H
Rinsho Ketsueki; 2010 Jan; 51(1):69-73. PubMed ID: 20134143
[TBL] [Abstract][Full Text] [Related]
33. Defibrotide treatment but not prophylaxis is useful in hepatic sinusoidal obstruction syndrome in children undergoing autologous stem cell transplant following high-dose chemotherapy: A single-center experience from the Royal Marsden Hospital, UK.
Roy Moulik N; Johnson I; Van Bruggen L; Petterson T; Mycroft J; Vaidya SJ
Pediatr Blood Cancer; 2020 Nov; 67(11):e28677. PubMed ID: 32865880
[TBL] [Abstract][Full Text] [Related]
34. Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study.
Picod A; Bonnin A; Battipaglia G; Giannotti F; Ruggeri A; Brissot E; Malard F; Médiavilla C; Belhocine R; Vekhoff A; Gueye MS; Lapusan S; Adaeva R; Isnard F; Legrand O; Baylatry MT; Joly AC; Labopin M; Duléry R; Mohty M
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1471-1475. PubMed ID: 29477779
[TBL] [Abstract][Full Text] [Related]
35. Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Kernan NA; Grupp S; Smith AR; Arai S; Triplett B; Antin JH; Lehmann L; Shore T; Ho VT; Bunin N; Iacobelli M; Liang W; Hume R; Tappe W; Soiffer R; Richardson P
Br J Haematol; 2018 Jun; 181(6):816-827. PubMed ID: 29767845
[TBL] [Abstract][Full Text] [Related]
36. Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant.
Nauffal M; Kim HT; Richardson PG; Soiffer RJ; Antin JH; Cutler C; Nikiforow S; Gooptu M; Koreth J; Romee R; Ho VT
Blood Adv; 2022 Jan; 6(1):181-188. PubMed ID: 34666352
[TBL] [Abstract][Full Text] [Related]
37. Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.
De Ramón Ortiz C; Justo Sanz R; Beauverd Y; Humala K; López de la Guia A; De Paz R; Gasior M; Gómez Prieto P; Fabra Urdiola M; Canales Albendea M; Butta N; Jiménez Yuste V
Dis Markers; 2023; 2023():7589017. PubMed ID: 37101837
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor-I predicts sinusoidal obstruction syndrome following pediatric hematopoietic stem cell transplantation.
Ebbesen M; Weischendorff S; Kielsen K; Kammersgaard M; Juul A; Müller KG
Bone Marrow Transplant; 2021 May; 56(5):1021-1030. PubMed ID: 33219341
[TBL] [Abstract][Full Text] [Related]
39. Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome.
Lai X; Liu L; Zhang Z; Shi L; Yang G; Wu M; Huang R; Liu R; Lai Y; Li Q
Bone Marrow Transplant; 2021 Jul; 56(7):1635-1641. PubMed ID: 33608657
[TBL] [Abstract][Full Text] [Related]
40. Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program.
Kernan NA; Richardson PG; Smith AR; Triplett BM; Antin JH; Lehmann L; Messinger Y; Liang W; Hume R; Tappe W; Soiffer RJ; Grupp SA
Pediatr Blood Cancer; 2018 Oct; 65(10):e27269. PubMed ID: 29873895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
